AERIE PHARMACEUTICALS INC - COM (AERI)

Historical Holders from Q1 2014 to Q4 2022

Symbol: AERI
Type / Class: Equity / COM
All holders as of 31 Dec 2022: Q4 2022
Total 13F shares, excl. options: 0
Holdings value: $0
Number of holders: 0
Number of sells: -146
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2022 Q4	0	$0	-$673,809,821	$0	$0		0
2022 Q3	46,931,778	$710,088,353	+$45,666,754	$303,000	$502,000	$15.13	149
2022 Q2	47,139,498	$353,564,770	-$6,565,439	$0	$92,000	$7.5	129
2022 Q1	48,049,364	$436,953,475	+$14,711,989	$107,000	$100,000	$9.1	130
2021 Q4	47,290,010	$332,084,902	-$7,111,865	$172,200	$831,000	$7.02	126
2021 Q3	46,314,938	$527,879,513	-$10,249,304	$1,028,000	$1,736,000	$11.4	133
2021 Q2	45,691,884	$731,682,748	-$7,842,098	$304,000	$199,000	$16.01	140
2021 Q1	46,063,476	$823,150,946	+$42,521,553	$5,004,000	$2,836,000	$17.87	157
2020 Q4	44,576,425	$602,221,671	-$27,794,254	$143,000	$1,504,000	$13.51	146
2020 Q3	46,856,606	$551,724,111	-$22,200,101	$531,000	$1,232,000	$11.77	144
2020 Q2	48,384,504	$712,391,078	-$58,543,811	$1,264,000	$566,000	$14.76	152
2020 Q1	51,997,908	$700,292,632	-$98,928,953	$5,279,000	$585,000	$13.5	146
2019 Q4	57,673,548	$1,393,690,562	+$38,775,758	$5,744,000	$15,400,000	$24.17	160
2019 Q3	56,692,743	$1,090,032,848	+$113,649,550	$5,598,000	$15,399,000	$19.22	163
2019 Q2	48,371,728	$1,429,265,419	-$10,463,802	$8,793,000	$15,606,000	$29.55	159
2019 Q1	47,461,401	$2,254,412,796	-$50,380,882	$4,799,000	$5,806,000	$47.5	168
2018 Q4	49,448,817	$1,784,968,110	-$13,294,176	$5,780,000	$8,909,000	$36.1	156
2018 Q3	47,933,815	$2,950,054,648	+$259,913,978	$11,043,000	$24,864,000	$61.55	174
2018 Q2	43,663,491	$2,949,433,796	+$53,650,639	$11,951,000	$19,020,000	$67.55	173
2018 Q1	42,933,190	$2,329,098,644	+$249,794,827	$20,767,000	$14,393,000	$54.25	168
2017 Q4	38,278,856	$2,287,865,048	+$20,554,967	$8,626,000	$27,573,000	$59.75	174
2017 Q3	37,612,365	$1,828,034,305	+$150,263,690	$16,253,000	$33,294,000	$48.6	178
2017 Q2	34,467,544	$1,811,286,824	+$117,879,421	$10,473,000	$8,669,000	$52.55	172
2017 Q1	32,370,498	$1,467,996,687	+$64,815,744	$5,320,000	$16,189,000	$45.35	156
2016 Q4	33,763,352	$1,277,904,525	+$46,542,763	$2,729,000	$5,995,000	$37.85	150
2016 Q3	32,439,327	$1,224,263,296	+$176,293,073	$18,896,000	$26,864,000	$37.74	161
2016 Q2	27,773,716	$488,823,497	+$18,248,950	$562,000	$2,837,000	$17.6	103
2016 Q1	26,614,668	$323,615,000	+$7,011,091	$758,000	$1,066,000	$12.16	100
2015 Q4	24,161,831	$588,340,090	-$6,239,953	$1,887,000	$2,549,000	$24.35	112
2015 Q3	24,632,437	$436,838,504	+$18,282,454	$2,640,000	$27,268,000	$17.74	113
2015 Q2	23,604,285	$415,963,144	-$30,985,635	$2,564,000	$4,876,000	$17.65	106
2015 Q1	22,129,453	$693,309,938	+$28,837,028	$1,255,000	$7,760,000	$31.34	122
2014 Q4	21,463,770	$626,614,711	+$50,471,026			$29.19	98
2014 Q3	19,543,479	$404,350,425	+$77,358,368			$20.69	75
2014 Q2	12,199,246	$302,175,492	+$44,712,233			$24.77	58
2014 Q1	10,620,215	$225,044,376	+$4,600,185			$21.19	50